Decreased interleukin-37 expression in vogt-koyanagi-harada disease and upregulation following immunosuppressive treatment

Journal of Interferon and Cytokine Research

Volumn 35, Issue 4, 2015, Pages 265-272

  Ye, Zi ^a   Wang, Chaokui ^a   Tang, Jihong ^a   Zhou, Yan ^a   Bai, Lin ^a   Liu, Yunjia ^a   Kijlstra, Aize ^b   Yang, Peizeng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; CYTOKINE; DEXAMETHASONE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 27; INTERLEUKIN 37; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CORTICOSTEROID; IL37 PROTEIN, HUMAN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; INTRAOCULAR INFLAMMATION; MALE; MIDDLE AGED; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; TREATMENT DURATION; UPREGULATION; VOGT KOYANAGI SYNDROME; YOUNG ADULT; CELL CULTURE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; UVEOMENINGOENCEPHALITIC SYNDROME;

ADRENAL CORTEX HORMONES; ADULT; AGED; CELLS, CULTURED; CHILD; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-1; MALE; MIDDLE AGED; UVEOMENINGOENCEPHALITIC SYNDROME;

EID: 84926469464     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2014.0042     Document Type: Article

References (30)

1. Batten M, Li J, Yi S, Kljavin NM, Danilenko DM, Lucas S, Lee J, de Sauvage FJ, Ghilardi N. 2006. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 7:929-936.
2. Boraschi D, Lucchesi D, Hainzl S, Leitner M, Maier E, Mangelberger D, Oostingh GJ, Pfaller T, Pixner C, Posselt G, et al. 2011. IL-37: a new anti-inflammatory cytokine of the IL-1 family. Eur Cytokine Netw 22:127-147.
3. Chi W, Yang P, Li B, Wu C, Jin H, Zhu X, Chen L, Zhou H, Huang X, Kijlstra A. 2007. IL-23 promotes CD4 + T cells to produce IL-17 in Vogt-Koyanagi-Harada disease. J Allergy Clin Immunol 119:1218-1224.
4. Commodaro AG, Peron JP, Genre J, Arslanian C, Sanches L, Muccioli C, Rizzo LV, Belfort R, Jr. 2010. IL-10 and TGFbeta immunoregulatory cytokines rather than natural regulatory T cells are associated with the resolution phase of Vogt-Koyanagi-Harada (VKH) syndrome. Scand J Immunol 72:31-37.
5. Damico FM, Cunha-Neto E, Goldberg AC, Iwai LK, Marin ML, Hammer J, Kalil J, Yamamoto JH. 2005. T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1∗0405-positive and-negative Vogt-Koyanagi-Harada uveitis. Invest Ophthalmol Vis Sci 46:2465-2471.
6. Egwuagu CE, Sztein J, Mahdi RM, Li W, Chao-Chan C, Smith JA, Charukamnoetkanok P, Chepelinsky AB. 1999. IFNgamma increases the severity and accelerates the onset of experimental autoimmune uveitis in transgenic rats. J Immunol 162:510-517.
7. Fitzgerald DC, Zhang GX, El-Behi M, Fonseca-Kelly Z, Li H, Yu S, Saris CJ, Gran B, Ciric B, Rostami A. 2007. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat Immunol 8:1372-1379.
8. Horai R, Caspi RR. 2011. Cytokines in autoimmune uveitis. J Interferon Cytokine Res 31:733-744.
9. Imai Y, Sugita M, Nakamura S, Toriyama S, Ohno S. 2001. Cytokine production and helper T cell subsets in Vogt-Koyanagi-Harada's disease. Curr Eye Res 22:312-318.
10. Lanzavecchia A, Sallusto F. 2001. The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. Curr Opin Immunol 13:291-298.
11. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402-408.
12. McNamee EN, Masterson JC, Jedlicka P, McManus M, Grenz A, Collins CB, Nold MF, Nold-Petry C, Bufler P, Dinarello CA, et al. 2011. Interleukin 37 expression protects mice from colitis. Proc Natl Acad Sci U S A 108:16711-16716.
13. Mosser DM, Zhang X. 2008. Interleukin-10: new perspectives on an old cytokine. Immunol Rev 226:205-218.
14. Nold MF, Nold-Petry CA, Zepp JA, Palmer BE, Bufler P, Dinarello CA. 2010. IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol 11:1014-1022.
15. Ooi KG, Galatowicz G, Calder VL, Lightman SL. 2006. Cytokines and chemokines in uveitis: is there a correlation with clinical phenotype? Clin Med Res 4:294-309.
16. Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, Pivetti-Pezzi P, Tessler HH, Usui M. 2001. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 131:647-652.
17. Read RW, Rao NA, Cunningham ET. 2000. Vogt-Koyanagi-Harada disease. Curr Opin Ophthalmol 11:437-442.
18. Read RW, Yu F, Accorinti M, Bodaghi B, Chee SP, Fardeau C, Goto H, Holland GN, Kawashima H, Kojima E, et al. 2006. Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease. Am J Ophthalmol 142:119-124.
19. Sabat R, Grutz G, Warszawska K, Kirsch S, Witte E, Wolk K, Geginat J. 2010. Biology of interleukin-10. Cytokine Growth Factor Rev 21:331-344.
20. Sakaguchi M, Sugita S, Sagawa K, Itoh K, Mochizuki M. 1998. Cytokine production by T cells infiltrating in the eye of uveitis patients. Jpn J Ophthalmol 42:262-268.
21. Sallusto F, Lanzavecchia A. 2002. The instructive role of dendritic cells on T-cell responses. Arthritis Res 4 (Suppl. 3): S127-S132.
22. Song L, Qiu F, Fan Y, Ding F, Liu H, Shu Q, Liu W, Li X. 2013. Glucocorticoid regulates interleukin-37 in systemic lupus erythematosus. J Clin Immunol 33:111-117.
23. Stumhofer JS, Laurence A, Wilson EH, Huang E, Tato CM, Johnson LM, Villarino AV, Huang Q, Yoshimura A, Sehy D, et al. 2006. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol 7:937-945.
24. Sugita S, Takase H, Taguchi C, Imai Y, Kamoi K, Kawaguchi T, Sugamoto Y, Futagami Y, Itoh K, Mochizuki M. 2006. Ocular infiltrating CD4 + T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens. Invest Ophthalmol Vis Sci 47:2547-2554.
25. Sun M, Yang P, Du L, Zhou H, Ren X, Kijlstra A. 2010. Contribution of CD4 + CD25 + T cells to the regression phase of experimental autoimmune uveoretinitis. Invest Ophthalmol Vis Sci 51:383-389.
26. Vitale AT, Rodriguez A, Foster CS. 1996. Low-dose cyclosporin A therapy in treating chronic, noninfectious uveitis. Ophthalmology 103:365-373; discussion 373-374.
27. Wang C, Tian Y, Lei B, Xiao X, Ye Z, Li F, Kijlstra A, Yang P. 2012. Decreased IL-27 expression in association with an increased Th17 response in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci 53:4668-4675.
28. Yang P, Ren Y, Li B, Fang W, Meng Q, Kijlstra A. 2007. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients. Ophthalmology 114:606-614.
29. Ye Z, Huang H, Hao S, Xu S, Yu H, Van Den Hurk S, Xiang J. 2007. IL-10 has a distinct immunoregulatory effect on naive and active T cell subsets. J Interferon Cytokine Res 27:1031-1038.
30. Ye Z, Wang C, Kijlstra A, Zhou X, Yang P. 2014. A possible role for interleukin 37 in the pathogenesis of Behcet's disease. Curr Mol Med 14:535-542.